期刊文献+

人纤溶酶原激活剂抑制物2型(PAI-2)在大肠杆菌中的表达和分离纯化 被引量:3

Expression and Purification of Human Plasminogen Activator Inhibitor Type 2 in E.coli
下载PDF
导出
摘要 用PCR方法从pPAIJ.7中扩增人纤溶酶原激活剂抑制物2型(PAI-2)cDNA,与pUC18重组,经限制性内切酶片段分析与核苷酸序列分析,获得全长人PAI-2cDNA.PAI-2cDNA与原核表达载体重组,构建原核表达质粒并转化大肠杆菌.经温度诱导表达,重组PAI-2占全菌总蛋白的14%,以可溶性形式存在,具纤溶抑制活性.工程菌发酵、压榨后,用硫酸铵分级沉淀,沉淀物经分子筛、离子交换和疏水性色谱的分离,每升菌液可获得约30mg纯度达90%的蛋白质,比活性为11866AIU/mg蛋白质,得率为19.2%. To express human plasminogen activator inhibitor type 2(PAI 2)in E.coli and establish a method for the purificaton of the recombinant protein (rhPAI 2),PAI 2 cDNA was amplified by PCR,using pPAIJ.7 containing human PAI 2 cDNA as a templete. After restriction enzyme analysis and DNA sequencing,the PCR product was ligated with prokaryotic expression vector and transfected a special strain of E.coli. The expression product was identified by Western blot.The biological activity was measured by chromogenic assay.The solube rhPAI 2 was purified by a protocal which included ammonium sulfate precipitation,Sephadex G 75 gel filtration,Q sepharose ion exchange chromatography and hydrophobic interaction chromatography.The expressed recombinant PAI 2 was about 14% of total bacteria protein,and was identical to PAI 2 with respect to interaction with polyclonal antibody.The purity of rhPAI 2 was up to 90%,the protein yielding 30 mg per liter of culture,the specific activity of rhPAI 2 was 11 866 AIU/ mg,and rhPAI 2 was found to inhibit u PA by forming SDS resistant complex.
出处 《中国生物化学与分子生物学报》 CAS CSCD 1998年第5期536-541,共6页 Chinese Journal of Biochemistry and Molecular Biology
基金 国家自然科学基金
关键词 原核表达 分离纯化 PAI-2 大肠杆菌 Plasminogen activator inhibitor type 2(PAI 2) Expression in E.coli Purification
  • 相关文献

参考文献2

二级参考文献5

  • 1贾海燕,中华心血管病杂志,1988年
  • 2王结义,国外医学分子生物学分册,1987年,9期,164页
  • 3王结义,国外医学分子生物学分册,1987年,9期,29页
  • 4贾海燕,上海医科大学学报,1987年,14卷,375页
  • 5王结义,上海医科大学学报,1987年,14卷,179页

共引文献31

同被引文献23

  • 1王结义,贾海燕.人血浆组织型纤溶酶原激活剂及其抑制物活性的测定[J].中华医学检验杂志,1989,12(3):163-166. 被引量:32
  • 2Tian Y,上海医科大学学报,1998年,2 5卷,3期,1页
  • 3Gan H X,J Immunol,1995年,15 5卷,1304页
  • 4Lai L H,Prediction of Protein Structure and the Principles of Protein Conformation,1993年,22页
  • 5Wang J Y,中华医学检验杂志,1989年,12卷,3期,163页
  • 6Schmitt M, Wilhelm O G, Reuning U, Kruger A, Harbeck N, Lengyel E, Magdolen V. The urokinase plasminogen activator system as a novel target for tumor therapy. Fibrinolysis, 2000, 14(2/3): 114 - 132
  • 7Dichinson J L, Bates E J, Ferrante A, Antalis T M. Plasminogen activator inhibitor type-2 inhibitors tumour necrosis factor α induced apoptosis. J Biol Chem, 1995, 270(46): 27894 - 27904
  • 8田昱 沈俊卿 李平 朱运松.Pal—2抑制细胞凋亡依赖其蛋白质结合功能域[J].Acta Biochinica et Biophysica Sinica(生物化学与生物物理学报:英文版),.
  • 9Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A La boratory Manual, 2nd ed. New York: Cold Spring Harbor Laboratory Press.1989
  • 10Janson JC, Ryden L. Protein purifcation. 2nd ed. New York: John Wiley & Sons, Inc, Publication. 1998

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部